Bryan D. Marks

Highly Miniaturized Formats for In Vitro Drug Metabolism Assays Using Vivid® Fluorescent Substrates and Recombinant Human Cytochrome P450 Enzymes

Olga V. Trubetskoy, Jasmin Gibson, Bryan D. Marks · SLAS DISCOVERY · 2005 · 86 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +17

Development and Applications of a Broad-Coverage, TR-FRET-Based Kinase Binding Assay Platform

Connie S. Lebakken, Steven M. Riddle, Upinder Singh et al. · SLAS DISCOVERY · 2009 · 80 citations · Full text

Life Sciences, Molecular Biology, Drug Discovery +15

Identification of Pregnane X Receptor Ligands Using Time-Resolved Fluorescence Resonance Energy Transfer and Quantitative High-Throughput Screening

Sunita J. Shukla, Ðắc-Trung Nguyễn, Ryan MacArthur et al. · Assay and Drug Development Technologies · 2009 · 61 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +16

The Androgen Receptor T877A Mutant Recruits LXXLL and FXXLF Peptides Differently than Wild-Type Androgen Receptor in a Time-Resolved Fluorescence Resonance Energy Transfer Assay

Mary Szatkowski Ozers, Bryan D. Marks, Krishne Gowda et al. · Biochemistry · 2006 · 59 citations

Life Sciences, Molecular Biology, Pharmacology +17

Development of the Predictor hERG Fluorescence Polarization Assay Using a Membrane Protein Enrichment Approach

David R. Piper, Steve R. Duff, Hildegard C. Eliason et al. · Assay and Drug Development Technologies · 2008 · 52 citations · Full text

Medicine, Molecular Biology, Pharmacology +14